OptimizeRx appoints Stephen Silvestro as CEO effective March 10, 2025

OptimizeRx Corp

Stephen Silvestro, previously interim CEO and President, appointed permanent CEO as of March 10, 2025.
Silvestro receives $500,000 annual base salary, target bonus of 80%, and $1.0M one-time equity grant.
Silvestro joined OptimizeRx in 2019 as CCO; served as President from Oct 2023; prior roles at CCH Tagetik, Prognos Health, Decision Resources Group.
Board conducted rigorous search with executive search firm; unanimous decision to appoint Silvestro, per Chair Lynn Vos.
Silvestro aims to focus on customer centricity, recurring revenue model, and becoming a Rule of 40 company.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Silvestro

Chief Executive Officer

OPRX · OptimizeRx Corp

Effective: 2025-03-10
Filed: March 10, 2025, 7:59 PM ET

announced that Stephen Silvestro has been appointed to serve as the Company’s Chief Executive Officer, effective as of March 10, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Silvestro was appointed as Chief Executive Officer at OptimizeRx Corp.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

announced that Stephen Silvestro has been appointed to serve as the Company’s Chief Executive Officer, effective as of March 10, 2025

View on SEC.gov

OptimizeRx Corp filing history →

Source: SEC EDGAR

accession 0001213900-25-021923

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.